Skip to main content
. Author manuscript; available in PMC: 2016 Oct 14.
Published in final edited form as: Mucosal Immunol. 2016 Feb 17;9(6):1584–1595. doi: 10.1038/mi.2016.12

Figure 6. Enhancement of phagocytic activity via Fc-engineering.

Figure 6

Phagocytic activity of macrophages (a) and neutrophils (b) to immune complexes was evaluated using a VRC01 WT and its Fc-enhanced variants at 4μg/ml (open circle, no antibody; closed circle, wild type VRC01; open square, SDIEGA, enhanced FcRγIIa affinity; closed square, SEHFST, enhanced C1q (complement) affinity; open triangle, SDIE, enhanced FcRγIIIa affinity; closed triangle, SDIEAL, enhanced FcRγIIIa affinity). Phagocytic score is depicted.